Pyro Pharmaceuticals Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Pyro Pharmaceuticals General Information

Description

Provider of pharmaceutical research services. The company is engaged in the research and development of drugs and pharmaceutical products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
BSKB Medical Ventures
Primary Office
  • 315 Marna Avenue
  • Long Beach, CA 90808
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pyro Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pyro Pharmaceuticals‘s full profile, request access.

Request a free trial

Pyro Pharmaceuticals Patents

Pyro Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060094075-A1 Methods for indentifying compounds that modulate an enzyme in the coenzyme a biosynthetic pathway in a pathogenic microoganism Abandoned 14-Feb-2002 00000000
US-20060252113-A1 Methods for identifying compounds that modulate an enzyme in the glucose metabolic pathway of a pathogenic microorganism Abandoned 14-Feb-2002 00000000
US-20060178320-A1 Methods for indentifying compounds that modulate an enzyme involved in thiamine metabolism in a pathogenic microorganism Abandoned 14-Feb-2002 00000000
US-20060178321-A1 Methods for indentifying compounds that modulate an enzyme involved in reductive carboxylation in a pathogenic microorganism Abandoned 14-Feb-2002 00000000
US-20030180830-A1 Identifying a metabolic pathway in a pathogenic microorganism that is essential to the viability of the microorganism, detecting an enzyme in such pathway which is not present in the mammal, identifying the compound that inhibit the enzyme Granted 14-Feb-2002 C12Q1/18 0

Pyro Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Alan Schechter Chief Executive Officer and Chairman
To view Pyro Pharmaceuticals’s complete executive team members history, request access »

Pyro Pharmaceuticals Board Members (1)

Name Representing Role Since
0000 000000000 Pyro Pharmaceuticals Chief Executive Officer and Chairman 000 0000
To view Pyro Pharmaceuticals’s complete board members history, request access »